NEW YORK, May 26, 2017 /PRNewswire/ --
Stock-Callers.com has initiated coverage on these four Scientific and Technical
San Francisco, California headquartered Fitbit Inc.'s stock finished Thursday's session 1.82% lower at $5.39 with a total trading volume of 4.96 million shares. The Company's shares are trading below their 50-day moving average by 6.00%. Shares of the Company, which designs and sells connected health and fitness tracking devices, have a Relative Strength Index (RSI) of 40.29.
On May 03rd, 2017, Fitbit announced Q1 2017 results. Revenue was $299 million, GAAP net loss per share was ($0.27), non-GAAP net loss per share was ($0.15), GAAP net loss was ($60.1) million, and adjusted EBITDA loss was ($52.3) million for Q1 2017. Gross margin was 39.6% for the quarter; non-GAAP gross margin was 40.0%; GAAP operating expenses were $210 million; and non-GAAP operating expenses were $182 million. Your complete research report on FIT can be retrieved for free at:
Shares in Sunnyvale, California headquartered Trimble Inc. climbed 0.28%, ending yesterday's session at $35.79 with a total trading volume of 476,843 shares. The stock has gained 10.67% in the past month, 13.98% in the previous three months, and 18.71% on an YTD basis. The Company's shares are trading 8.35% above their 50-day moving average and 19.19% above their 200-day moving average. Moreover, shares of Trimble, which provides technology solutions to enhance the work processes of office and mobile field professionals worldwide, have an RSI of 62.36.
On April 28th, 2017, research firm Needham reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $33 a share to $37 a share.
On May 24th, 2017, Trimble announced that it has signed an agreement to acquire privately held Müller-Elektronik, a German company specializing in implement control and precision farming solutions. The transaction is expected to close in Q3 2017, subject to customary closing conditions and clearance or expiration of the waiting period under the German Act Against Restraints of Competition. Financial terms were not disclosed. A free report on TRMB is just a click away at:
On Thursday, Natick, Massachusetts headquartered Cognex Corp.'s stock rose 0.61%, to close the day at $92.99. A total volume of 524,934 shares was traded. The Company's shares have advanced 9.93% in the last one month, 19.49% in the previous three months, and 46.16% on an YTD basis. The stock is trading 9.09% and 40.25% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Cognex, which provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide, have an RSI of 65.92.
On May 16th, 2017, Cognex announced that John J. Curran, Senior Vice President and CFO, will discuss the Company's performance and future prospects at the Baird 2017 Global Consumer, Technology & Services Conference on June 06th, 2017, at 10:15 a.m. ET, at the InterContinental New York Barclay in New York. Mr. Curran will also discuss the same at the Deutsche Bank 8th Annual Global Industrials & Materials Summit on June 07th, 2017, at 10:20 a.m. ET, at the Westin Chicago River North in Chicago. Sign up for your complimentary research report on CGNX at:
Shares in Everett, Washington-based Fortive Corp. ended the day 0.89% higher at $63.64. A total volume of 1.04 million shares was traded. The stock has gained 2.23% in the last one month, 10.12% in the previous three months, and 18.66% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 4.30% and 14.92%, respectively. Furthermore, shares of Fortive, which owns and operates industrial units that manufacture testing and measurement equipment, have an RSI of 66.38.
On April 27th, 2017, Fortive announced results for Q1 2017. Net earnings were $199.7 million and diluted net earnings per share were $0.57 for the quarter. GAAP revenues for Q1 2017 increased 4.1% year-over-year to $1.5 billion, with core revenue growth of 4.9%.
On May 02nd, 2017, research firm Morgan Stanley downgraded the Company's stock rating from 'Overweight' to 'Equal-Weight'. Register for free on Stock-Callers.com and download the latest research report on FTV at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All